Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.Number of contributors: 7 (all of which have been updated or confirmed before the report)XVIVO Perfusion’s Q2 report will be released on Tuesday 14 July at 07.30 CEST.AttachmentsXVIVO Perfusion – Consensus estimates Q2 2026
Estimates compiled by Modular Finance on behalf of XVIVO Perfusion.
Number of contributors: 7 (all of which have been updated or confirmed before the report)
KPI (MSEK, unless otherwise specified)Q2 2026E
Net sales234
Organic growth in local currency (%)33.58
Gross profit170
EBITDA47.9
EBIT28.0
Net profit21.9
Earnings per share (SEK)0.70
XVIVO Perfusion’s Q2 report will be released on Tuesday 14 July at 07.30 CEST.
